002050三花股份股票_002852股票

Profectus BioSciences
Profectus is a clinical-stage vaccine development company bringing a fundamental new approach to designing preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy by finely tuning immune response to the specific target.  
© 002050三花股份股票_002852股票 2017 Profectus BioSciences, Inc. All Rights Reserved.  |  User Login